Symbol
| GLIS3
| contributors: mct/pgu - updated : 11-04-2015
|
HGNC name
| GLIS family zinc finger 3
|
HGNC id
| 28510
|
corresponding disease(s)
|
NDH
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
| loss of function
|
leads to the development of cystic renal disease, suggesting that it plays a critical role in maintaining normal renal functions | constitutional
|  
|  
|  
| gain of function
|
involves a primary cilium-associated signal pathway | constitutional
|  
|  
|  
| loss of function
|
leads to the development of neonatal diabetes and polycystic kidney disease | |
Susceptibility
|
to type 2 diabetes to decreased glucose-stimulated insulin response |
Variant & Polymorphism
SNP
| rs7034200 displayed evidence for association with type 2 diabetes |
|
variants at the DGKB/AGMO, ADRA2A, GLIS3 and C2CD4B loci were associated with decreased glucose-stimulated insulin response |
|
|
Candidate gene
Marker
Therapy target
| | | |
| Glis3 mutant mice exhibit abnormalities very similar to those displayed by NDH1 patients, | |
including a greatly reduced life span and development of polycystic kidneys and neonatal diabetes |